AlphAIAlphAI — Financial news for AI agents
finance.yahoo.com$STLN

Oncology Institute Q3 Earnings Call Highlights

Oncology Institute (STLN) reported Q3 gross profit of $30.7M, up from $18.9M, with gross margin increasing to 18.1%. Capitated revenue rose 39.5% to $28.7M, while fee-for-service revenue fell 21% to $31.3M. The company expects 100% capitated revenue growth in 2027 and updated its 2026 outlook, including revenue of $650M-$660M and gross profit of $107M-$110M. STLN ended Q3 with $36.9M in cash.

Original reporting
finance.yahoo.com
Published Nov 6, 2026, 2:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 2:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Oncology Institute Q3 Earnings Call Highlights — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$STLNBullishMed
01

Why it matters

The earnings beat and raised guidance could attract buying interest, but operational delays may temper enthusiasm.

02

Market read

First disclosure of Q3 results and guidance; material for traders evaluating healthcare exposure.

03

What to watch

Potential headwinds from contract timing issues and higher medical loss ratios could curb profitability.

Relevance 8/10Novelty 8/10Timing: post‑earnings today

Background

Oncology Institute (NASDAQ:STLN) reported Q3 results and provided 2026 outlook, highlighting capitation growth and a delayed Florida expansion.

Company-level read

Ticker impact

$STLNBullishHigh confidence
Context

Q3 earnings released with updated 2026 guidance on revenue, gross profit and EBITDA.

Expected impact

likely upward pressure as market prices in higher revenue guidance

Evidence & confidence

Guidance above prior expectations and strong cash position suggest improved earnings trajectory.

Market effects

Sector

Positive earnings may lift other value‑based oncology and healthcare services stocks.

Regional

U.S. healthcare sector could see modest gains.

Global

Limited to U.S. healthcare investors.

Counterpoint

What could challenge this read

Guidance may be overly optimistic given delayed Florida rollout; risk of missed targets.

Key entities

  • company
    Oncology Institute

    Value‑based oncology care provider.

Read at source← All news

Related articles

$STLNMed

Starling Oncology Reports Third Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance

Starling Oncology, Inc. (STLN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE Starling Oncology Reports Third Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance CERRITOS, Calif., November 5, 2026 -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community o

SEC EDGAR 8-K
$CGONHigh

Why is CG Oncology stock surging today?

CG Oncology (CGON) stock rose 19.7% after Q3 2026 results showed a smaller-than-expected loss of $0.64 per share and revenue of $1.60M, both beating estimates. The company announced upcoming clinical trial data and a BLA submission, with a cash position of $984.5M. Analysts have a 'Moderate Buy' rating and $87.50 average price target.

investing.com
$GMEDHighAI 8/10

Why is Globus Medical stock plunging today?

Globus Medical (GMED) stock fell 12.5% to $71.26, a 52-week low, after Q3 2026 revenue missed estimates at $763.7M, down 0.7% YoY. The company cut full-year revenue guidance to $3.09B. Analysts downgraded the stock, citing weak growth outlook and insider selling. The S&P 500 and Nasdaq rose, but GMED underperformed.

investing.com
$BJRIMed

BJ's Restaurants (BJRI) Q3 2026 Earnings Call Transcript

BJ's Restaurants (BJRI) reported Q3 2026 earnings with restaurant-level operating profits up $11.5M and margins expanding 220 bps to 14.7%. Adjusted EBITDA rose $10.3M with margins up 240 bps to 8.8%. The company highlighted strong guest experience, effective growth drivers, and resilient consumer demand. Management expressed confidence in their strategy and guidance for the year.

finance.yahoo.com